The GvHD Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy
T-cell costimulation blockade with abatacept for acute GvHD: Results of the ABA2 trial
There are still no approved agents for preventing severe acute (a) graft-versus-host disease (GvHD), which is a major cause of non-relapse mortality (NRM).
Feb 25, 2021
|aGvHD
Mohamad Mohty
"The new GvHD Hub is an amazing resource for physicians and healthcare professionals in the field of GvHD. We have recently seen some great advances in this era, and the GvHD Hub is the place to go for the most up-to-date information."